Emollient topical disinfectants

Inventors

Kessler, Jack • LITZINGER, David C. • Rhodes, Christopher • CERRO, Andrew M.

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Assignees

I2Pure Corp

Member
I2Pure
I2Pure

I2Pure specializes in molecular iodine-based technologies for broad-spectrum infection prevention and biosafety across healthcare, consumer, and industrial markets. Its mission is to prevent pathogenic threats globally by developing, optimizing, and licensing stable, non-toxic molecular iodine solutions. The company focuses on formulation, clinical validation, manufacturing, and regulatory compliance related to antiseptic and antimicrobial products, supported by ongoing research into iodine chemistry, bioavailability, and delivery at biological interfaces. Its proprietary technology platform has potential applications across healthcare, industrial biosafety, consumer products, and food processing and can be delivered directly or through carriers in solutions, nanoparticles, polymers, and coatings.

Publication Number

US-11596648-B2

Patent

Publication Date

2023-03-07

Expiration Date


Abstract

This invention relates generally to an emollient topical composition of matter that contains molecular iodine with a reduced effective vapor pressure. In specific embodiments, the composition reduces the loss of molecular iodine to the atmosphere under storage conditions after application to mammalian tissue.

Core Innovation

The invention relates to an emollient topical antiseptic composition that comprises molecular iodine in a non-aqueous organic carrier, wherein the organic carrier molecule is selected from propylene glycol, glycerol, and combinations thereof. The composition is formulated to reduce effective vapor pressure of molecular iodine, thereby minimizing iodine loss to the atmosphere during storage and after application to mammalian tissue. This approach is presented as supporting stabilization of substantially pure molecular iodine for an extended period at room temperature.

A central aspect is that the ratio of molecular iodine to all iodine species is at least about 70% and is preferably at least about 90%, with an optimal 100% in the formulation. The vapor pressure of molecular iodine in the emollient antimicrobial composition is at least two magnitude lower than the vapor pressure of molecular iodine in water. The composition attributes include an organic carrier molecule having a carrier boiling point greater than 100°C and that the vapor phase is less than 30% of iodine.

The description contrasts the disclosed formulation concept with drawbacks associated with iodophor/film approaches and further discusses formulation tactics including low-vapor-pressure carriers and cyclodextrin inclusion cavities. Packaging concepts include single vs multi-compartment mixing, and composition components discussed for compatibility include cyclodextrins and certain polymers. Documented examples support iodine stability and compatibility across selected organic solvents and materials, including compatibility statements for specific polymer/cyclodextrin systems and iodine vapor pressure reduction using iodine-sensitive paper.

Claims Coverage

The independent claim defines an emollient antimicrobial composition with four core inventive requirements: (i) an organic carrier molecule selected from propylene glycol, glycerol, or combinations thereof; (ii) molecular iodine; (iii) a molecular-iodine-to-all-iodine-species ratio of at least about 70%; and (iv) molecular iodine vapor pressure in the emollient at least two magnitudes lower than in water. Dependent claims further refine composition ranges and specify additional formulation components and use contexts.

Emollient antimicrobial composition with propylene glycol or glycerol carrier

An organic carrier molecule selected from the group consisting of propylene glycol, glycerol, and a combination thereof.

Molecular iodine with defined molecular-iodine-to-all-iodine-species ratio

Molecular iodine, wherein the ratio of molecular iodine to all iodine species being at least about 70%.

Reduced molecular iodine vapor pressure versus water

The vapor pressure of molecular iodine in the emollient antimicrobial composition being at least two magnitude lower than the vapor pressure of molecular iodine in water.

Across the independent claim coverage, the inventive concept is an emollient antimicrobial composition that combines molecular iodine with an organic carrier selected from propylene glycol and glycerol, while enforcing both a high fraction of molecular iodine relative to all iodine species and a substantially reduced iodine vapor pressure compared with water.

Stated Advantages

Minimizes iodine loss to the atmosphere during storage and after application to mammalian tissue.

Enables stabilization of substantially pure molecular iodine for at least about 9 months at room temperature.

Maintains higher free iodine delivery than typical iodophors (as stated in the provided summary).

Reduces effective vapor pressure of molecular iodine compared to water (vapor pressure at least two magnitude lower).

Documented Applications

Topical antiseptic/emollient use on mammalian tissue, including storage and after application contexts (as described conceptually in the provided content).

Nasal cavity application for reducing MRSA, including comparison data versus a commercial povidone-iodine antiseptic product in a mouse model.

Hospital-acquired infection treatment involving Staphylococcus aureus, Pseudomonas aeruginosa, Acinetobacter baumannii, and Enterobacteriaceae including E. coli, Klebsiella pneumoniae, Shigella, or Yersinia.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.